FDA Approved: IMCIVREE — Supplemental Application (Rhythm Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved a supplemental application for IMCIVREE (setmelanotide) to expand its indications for genetic obesity disorders. The approval broadens use beyond t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bardet-biedl Syndrome
• Leptin Receptor Deficiency Obesity
• Pomc Deficiency Obesity

Drugs mentioned

• IMCIVREE (setmelanotide)

Snippet

SUPPL AP for IMCIVREE (SETMELANOTIDE)